GE HealthCare Technologies Inc.
GEHC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $5,143,000 | $5,006,000 | $4,777,000 | $5,319,000 |
| % Growth | 2.7% | 4.8% | -10.2% | – |
| Cost of Goods Sold | $3,153,000 | $3,023,000 | $2,765,000 | $3,044,000 |
| Gross Profit | $1,990,000 | $1,985,000 | $2,012,000 | $2,275,000 |
| % Margin | 38.7% | 39.7% | 42.1% | 42.8% |
| R&D Expenses | $292,000 | $302,000 | $344,000 | $344,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,045,000 | $1,029,000 | $1,040,000 | $1,130,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2,000 | -$1,000 | $0 |
| Operating Expenses | $1,337,000 | $1,329,000 | $1,383,000 | $1,474,000 |
| Operating Income | $653,000 | $654,000 | $629,000 | $801,000 |
| % Margin | 12.7% | 13.1% | 13.2% | 15.1% |
| Other Income/Exp. Net | -$10,000 | -$41,000 | $63,000 | $33,000 |
| Pre-Tax Income | $643,000 | $613,000 | $692,000 | $834,000 |
| Tax Expense | $179,000 | $113,000 | $104,000 | $96,000 |
| Net Income | $446,000 | $486,000 | $564,000 | $720,000 |
| % Margin | 8.7% | 9.7% | 11.8% | 13.5% |
| EPS | 0.98 | 1.06 | 1.23 | 1.58 |
| % Growth | -7.5% | -13.8% | -22.2% | – |
| EPS Diluted | 0.98 | 1.06 | 1.23 | 1.57 |
| Weighted Avg Shares Out | 456,000 | 457,000 | 457,000 | 457,000 |
| Weighted Avg Shares Out Dil | 457,000 | 458,000 | 459,000 | 459,000 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $6,000 | $0 | $0 |
| Interest Expense | $111,000 | $113,000 | $111,000 | $111,000 |
| Depreciation & Amortization | $148,000 | $148,000 | $136,000 | $140,000 |
| EBITDA | $902,000 | $874,000 | $939,000 | $1,085,000 |
| % Margin | 17.5% | 17.5% | 19.7% | 20.4% |